Shuttle reaches milestone in enrollment for Phase 2 trial of Ropidoxuridine
Shuttle Pharmaceuticals (SHPH) announced that it has achieved 25% enrollment in the initial randomized portion of its Phase 2 Clinical Trial of ...
Shuttle Pharma Reaches Milestone in Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
GAITHERSBURG, Md., Jan. 21, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage ...
Pharm Exec4d
AD04 Advancing to Phase III Amid Promising Results in Alcohol Use Disorder
Cary Claiborne, CEO, Adial Pharmaceuticals, discusses AD04’s development timeline and next steps towards approval for alcohol ...
Xenon Outlines Key Corporate Milestone Opportunities for 2025
Topline data from the first Phase 3 FOS study anticipated in H2 2025 representing major milestone in support of NDA filing and potential launch ...
Interesting Engineering on MSN13d
150 mph: UK’ firm’s electric aircraft achieves historic thrust-borne flight milestone
Vertical Aerospace’s VX4 aircraft achieves its first piloted thrust-borne flight maneuvers in 2025, setting new benchmarks.
devdiscourse5d
PVUNL's Milestone: Rail Connectivity Achieved Before Power Plant Launch
Patratu Vidyut Utpadan Nigam Limited (PVUNL) recently trialed a loco pilot in preparation for launching the first unit of its 3x800 MW power plant. This marks a significant milestone in achieving rail ...